Management of Staphylococcus aureus infections

David M Bamberger1, Sarah E Boyd

  • 1University of Missouri-Kansas City, School of Medicine, Kansas City, Missouri, USA. bambergerd@umkc.edu

American Family Physician
|December 24, 2005
PubMed

Insights

Staphylococcus aureus infections, including resistant strains, are a growing concern. New treatments exist, but adherence to basic precautions like handwashing remains suboptimal, increasing patient risk.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Staphylococcus aureus infections present significant challenges due to high incidence, morbidity, and rising antimicrobial resistance.
  • Vancomycin-resistant strains and community-acquired methicillin-resistant S. aureus (CA-MRSA) infections are increasingly recognized, posing substantial risks.
  • Suboptimal adherence to Centers for Disease Control and Prevention (CDC) recommended precautions, particularly handwashing, exacerbates the problem.

Purpose of the Study:

  • To highlight the growing concern of Staphylococcus aureus infections for family physicians.
  • To discuss the implications of antimicrobial resistance, including vancomycin resistance and CA-MRSA.
  • To review available treatments and the importance of preventive measures.

Main Methods:

  • Literature review and synthesis of current data on S. aureus infections.
  • Analysis of trends in incidence, morbidity, and antimicrobial resistance.
  • Discussion of clinical manifestations and treatment options.

Main Results:

  • S. aureus is a common cause of diverse infections, including skin, soft-tissue, and invasive conditions like bacteremia and endocarditis.
  • Antimicrobial resistance, notably vancomycin resistance and CA-MRSA, is a significant and increasing issue.
  • New antimicrobial agents like daptomycin and linezolid offer treatment options for complex infections.

Conclusions:

  • Staphylococcus aureus infections, especially resistant strains, require urgent attention from healthcare providers.
  • Effective management necessitates awareness of resistance patterns, appropriate use of new antimicrobial agents, and improved adherence to infection control practices.
  • Enhanced preventive strategies, including rigorous hand hygiene, are crucial to mitigate the spread and impact of S. aureus infections.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...